NAFLD

November 12, 2017

Molecular therapy for Non-alcoholic fatty liver disease (NAFLD): Victoza/Saxenda, an anti-hyperglycemic drug, promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 12/November/2017, 11.15 pm

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]
November 11, 2017

Natural product therapy for Non-alcoholic fatty liver disease (NAFLD): Mangiferin, isolated from Mangifera Indica, promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 11/November/2017, 11.40 pm

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]
November 8, 2017

Natural product therapy for Non-alcoholic fatty liver disease (NAFLD): Hesperidin, isolated from Citrus fruits, promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 8/November/2017, 10.37 pm

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]
November 4, 2017

Natural product therapy for Non-alcoholic fatty liver disease (NAFLD): Linalool, isolated from Coriander, Palmarosa, Sweet orange, and lavender, promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 4/November/2017, 11.58 pm

Significance of the study: Given that: (1)  15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]